⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15296656 | 0.76 | — | — | |
| SCHEMBL6725813 | 0.71 | — | — | |
| SCHEMBL7975732 | 0.71 | — | — | |
| SCHEMBL8009337 | 0.65 | — | — | |
| SCHEMBL12744875 | 0.65 | — | — | |
| SCHEMBL16965855 | 0.63 | — | — | |
| SCHEMBL54608 | 0.62 | — | — | |
| SCHEMBL9067452 | 0.60 | — | — | |
| SCHEMBL21707535 | 0.60 | ALDH1A1 (0.36) | — | |
| SCHEMBL11435255 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 557 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115650827-B | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-110655539-B | Method for synthesizing cis-difluoromethylcyclohexane derivatives and heterocyclic compounds by hydrogenation | 四川大学 | 2021-11-12 | — | — | CN | claimed |
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2021-04-29 | — | — | US | claimed |
| WO-2020054531-A1 | PLANT DISEASE CONTROL AGENT | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 2020-03-19 | — | — | WO | claimed |
| CN-110655539-A | Method for synthesizing cis-difluoromethylcyclohexane derivatives and heterocyclic compounds by hydrogenation | 四川大学 | 2020-01-07 | — | — | CN | claimed |
| CN-110627778-A | Compound containing 1,2, 4-oxadiazole ring, preparation method thereof and application thereof in immunosuppressive drugs | 中国科学院上海药物研究所 | 2019-12-31 | — | — | CN | claimed |
| CN-110573013-A | Plant disease control agent | 明治制果药业株式会社 | 2019-12-13 | — | — | CN | claimed |
| US-9487494-B2 | Cyclic hydrocarbon compounds for the treatment of diseases | LEO PHARMA A/S (DK) | 2016-11-08 | — | — | US | claimed |
| EP-1906945-B1 | HCV INHIBITORS | VIROBAY INC (US) | 2015-08-05 | — | — | EP | claimed |
| EP-1761517-B1 | NOVEL IMIDAZOLES AND TRIAZOLES, THE PRODUCTION THEREOF, AND THE USE OF THE SAME AS MEDICAMENTS | BOEHRINGER INGELHEIM INT (DE) | 2014-09-24 | — | — | EP | claimed |
| US-6127489-A | Silyl linker for solid phase organic synthesis of aryl-containing molecules | SMITHKLINE BEECHAM CORPORATION (US) | 2000-10-03 | — | — | US | claimed |
| EP-1027351-A1 | PHENANTHROLINE DERIVATIVES | FIBROGEN, INC. (US) | 2000-08-16 | — | — | EP | claimed |
| WO-1999021860-B1 | PHENANTHROLINE DERIVATIVES | FIBROGEN INC (US) | 1999-08-05 | — | — | WO | claimed |
| US-5916898-A | ANTIFIBROPROLIFERTIVE, ENZYME INHIBITORS OF PYROLYL 4-HYDROXYLASE, ANTIARTHRITIC AGENTS | ZENECA LIMITED (GB) | 1999-06-29 | — | — | US | claimed |
| WO-1999021860-A1 | PHENANTHROLINE DERIVATIVES | FIBROGEN, INC. (US) | 1999-05-06 | — | — | WO | claimed |
| US-5773512-A | Compounds and methods | SMITHKLINE BEECHAM CORP. (US) | 1998-06-30 | — | — | US | claimed |
| EP-0734398-A4 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORP (US) | 1997-04-16 | — | — | EP | claimed |
| EP-0734398-A1 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-10-02 | — | — | EP | claimed |
| WO-1995016712-A1 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-06-22 | — | — | WO | claimed |
| CN-1049164-A | Suppress Aminooligohydroxy derivatives of feritin and preparation method thereof | HOECHST AG (DE) | 1991-02-13 | — | — | CN | claimed |